Eczema: all 1,088 studies

Page 7 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid ArthritisStatus unknownNCT04815148Phase 1
• Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04805411Phase 2
• Characterizing Skin Microbiome Change in Atopic DermatitisCompletedNCT04800185Early Phase 1
• A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)CompletedNCT04772885Phase 1
• Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic DermatitisStatus unknownNCT04771910Not applicable
• An Innovative Probiotic Product With Antiallergic PropertiesCompletedNCT04738565Not applicable
• A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic DermatitisCompletedNCT04737304Phase 1/2
• Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic DermatitisCompletedNCT04728269Not applicable
• Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic DermatitisStatus unknownNCT04725136Phase 1/2
• Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic DermatitisActive, not recruitingNCT04717310Phase 2/3
• Efficacy of Oral Supplementation of Probiotics in Children With Atopic DermatitisCompletedNCT04706559Not applicable
• A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic DermatitisCompletedNCT04693195Phase 2
• Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencingStatus unknownNCT04681300
• Barrier Enhancement for Eczema PreventionCompletedNCT04680520Not applicable
• A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in BrazilWithdrawnNCT04666675Phase 3
• Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From EczemaStatus unknownNCT04617977Not applicable
• Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.Status unknownNCT04615962Phase 1
• Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisCompletedNCT04613037Early Phase 1
• A First-in-Human Study of CEE321 in Adult SubjectsCompletedNCT04612062Phase 1
• Skin Barrier Abnormalities and Oxidative Stress ResponseStatus unknownNCT04606615
• Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic DermatitisNo longer availableNCT04564755
• Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier FunctionCompletedNCT04556461Phase 2
• Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic DermatitisCompletedNCT04553224Not applicable
• Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic DermatitisCompletedNCT04539639Phase 2
• Development of a Method to Measure mRNA Levels in Skin SamplesCompletedNCT04537468Not applicable
• A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)CompletedNCT04530643Phase 2
• Hand Sanitizer Effects on the Skin BarrierStatus unknownNCT04525521
• An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic DermatitisStatus unknownNCT04520308Phase 4
• Dupilumab in Severe Chronic Hand EczemaStatus unknownNCT04512339Phase 2
• Paraffin Bath Therapy for Chronic Hand EczemaCompletedNCT04510961Not applicable
• Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic DermatitisCompletedNCT04504279Phase 2
• Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory DermatosisCompletedNCT04472546Not applicable
• Vitamin D in Egyptian Children With Atopic DermatitisCompletedNCT04468711Phase 3
• Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04462055
• Hand Eczema in the Health Care SectorStatus unknownNCT04449575
• Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.CompletedNCT04444726Not applicable
• Jaktinib Hydrochloride Cream For Atopic DermatitisCompletedNCT04435392Phase 1/2
• Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic DermatitisStatus unknownNCT04413942Phase 2
• Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early ChildhoodStatus unknownNCT04398758Phase 3
• A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis PatientsCompletedNCT04369846Phase 1/2
• Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic DermatitisCompletedNCT04362852
• Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and AsthmaStatus unknownNCT04354207
• A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis PatientsCompletedNCT04352595Phase 2
• Clinic-Based Atopic Dermatitis Therapeutic Patient EducationCompletedNCT04352270Not applicable
• Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate ADCompletedNCT04339985Phase 2
• Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist NaltrexoneWithdrawnNCT04325802Phase 2
• Comprehending Atopic Risk ElementsStatus unknownNCT04325451
• The Role of IL-22/IL-22BP Axis in Atopic DermatitisCompletedNCT04310189Not applicable
• The Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic DermatitisStatus unknownNCT04297215Not applicable
• Skin Pathology Assessment With Optical TechnologiesCompletedNCT04295824
• Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic DermatitisCompletedNCT04287608
• Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisStatus unknownNCT04283968Phase 3
• A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic DermatitisCompletedNCT04271514Phase 1
• Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone FuroatesCompletedNCT04271007Phase 4
• Topical L. Reuteri in Children With Atopic DermatitisStatus unknownNCT04265716Not applicable
• A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)TerminatedNCT04262791Phase 1
• A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic DermatitisCompletedNCT04256174Phase 1
• The Factors Affecting Atopic Dermatitis in Children Age 1-3CompletedNCT04218877
• A Pilot Study to Explore the Role of Gut Flora in EczemaWithdrawnNCT04214548
• Study of Crisaborole Ointment 2% in Mild to Moderate Atopic DermatitisStatus unknownNCT04214197Phase 4
• Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic DermatitisTerminatedNCT04211415Phase 1
• Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic DermatitisCompletedNCT04193670Not applicable
• Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. PlaceboTerminatedNCT04192513Phase 2
• Skin Tape Transcriptome Methods in ChildrenCompletedNCT04180644
• Stress-induced Scratching in Healthy and ADCompletedNCT04174651Not applicable
• Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate EczemaCompletedNCT04156191Phase 1
• Epidemiological Survey and Genetic Analysis of AD Patients in Hong KongStatus unknownNCT04154839
• Treatment of Chronic Itch in Atopic Dermatitis With Topical NaltrexoneWithdrawnNCT04154033Phase 2
• PGE2/IL-22 Pathway in Various Forms of EczemaCompletedNCT04133506
• A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic DermatitisTerminatedNCT04110873Phase 2
• Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier FunctionCompletedNCT04097327
• A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic DermatitisCompletedNCT04090229Phase 1
• Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis PatientsStatus unknownNCT04087863
• Effects of a Berry Oil Cream on Atopic Eczema and SkinTerminatedNCT04085549Not applicable
• Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema HerpeticumStatus unknownNCT04060550
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
• Response of Children With Atopic Dermatitis (Eczema) to EucrisaCompletedNCT04023084Phase 4
• Glutamine Supplementation in People With Immune DysregulationWithdrawnNCT04019769Early Phase 1
• The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard TherapyStatus unknownNCT04018131Phase 3
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic DermatitisCompletedNCT04018027Phase 2
• Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over TimeActive, not recruitingNCT04017520
• A Clinical Study of Adherence to Methylprednisolone Aceponate in Different CarriersCompletedNCT04016025Phase 4
• Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week PeriodCompletedNCT04008784
• Evaluating the Effect of Bathing Additives in Atopic DermatitisTerminatedNCT04001855Not applicable
• Evalution the Safety and Efficacy in Atopic Dermatitis PatientsStatus unknownNCT03962387
• A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisCompletedNCT03920852Phase 1
• Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064CompletedNCT03918980Phase 1
• Scratch Behavior Under Standard of CareCompletedNCT03898427
• Sweat and Gas Sensor for Healthy Skin and Atopic DermatitisCompletedNCT03874039
• Monitoring Of Scratch Via Accelerometry In ChildrenCompletedNCT03873220
• The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With EczemaCompletedNCT03873142Not applicable
• Short-term Topical Application to Prevent Atopic DermatitisCompletedNCT03871998Not applicable
• Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical CorticosteroidsCompletedNCT03861455Phase 2
• Study in Subjects With Moderate Atopic DermatitisStatus unknownNCT03859986Phase 2
• Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic DermatitisTerminatedNCT03846466Phase 1
• Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in ChildrenWithdrawnNCT03843437Not applicable
• PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
• Clinical, Psychological and Genetic Characteristics in Dermatological PatientsCompletedNCT03831646
• Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and ChildrenCompletedNCT03826901Phase 1
• Study to Evaluate the Use of a Probiotic in SCORAD Reduction in Young Patients With Atopic DermatitisStatus unknownNCT03822624Not applicable

← Eczema overview